Peptidylarginine deiminase type-4 (PADI4) inhibits p21 transcription by modifying histone H3 arginine at the p21 promoter region, which protects FLS from apoptosis and promotes the pathogenesis of RA (Fan et al., 2017). The gene discussed is PADI4; the disease is rheumatoid arthritis.